 | • レポートコード：MRC2-11QY01773 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインターフェロンアルファ-2bバイオシミラーのグローバル市場について調査・分析したレポートです。種類別（持続性タイプ、普通タイプ）市場規模、用途別（C型肝炎、B型肝炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インターフェロンアルファ-2bバイオシミラーの競争状況、市場シェア ・世界のインターフェロンアルファ-2bバイオシミラー市場：種類別市場規模 2015年-2020年（持続性タイプ、普通タイプ） ・世界のインターフェロンアルファ-2bバイオシミラー市場：種類別市場規模予測 2021年-2026年（持続性タイプ、普通タイプ） ・世界のインターフェロンアルファ-2bバイオシミラー市場：用途別市場規模 2015年-2020年（C型肝炎、B型肝炎、その他） ・世界のインターフェロンアルファ-2bバイオシミラー市場：用途別市場規模予測 2021年-2026年（C型肝炎、B型肝炎、その他） ・北米のインターフェロンアルファ-2bバイオシミラー市場分析：米国、カナダ ・ヨーロッパのインターフェロンアルファ-2bバイオシミラー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインターフェロンアルファ-2bバイオシミラー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインターフェロンアルファ-2bバイオシミラー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインターフェロンアルファ-2bバイオシミラー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pharmstandard、Sicor Biotech、Intas、Reliance Life Science、CCL Pharmaceuticals、Tianjin Hualida、Biosidus、Amega ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Interferon Alpha-2b Biosimilar Market
The global Interferon Alpha-2b Biosimilar market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Interferon Alpha-2b Biosimilar Scope and Market Size
Interferon Alpha-2b Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interferon Alpha-2b Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Interferon Alpha-2b Biosimilar market is segmented into
Long-lasting Type
Ordinary Type
Segment by Application, the Interferon Alpha-2b Biosimilar market is segmented into
Hepatitis C
Hepatitis B
Other
Regional and Country-level Analysis
The Interferon Alpha-2b Biosimilar market is analysed and market size information is provided by regions (countries).
The key regions covered in the Interferon Alpha-2b Biosimilar market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Interferon Alpha-2b Biosimilar Market Share Analysis
Interferon Alpha-2b Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interferon Alpha-2b Biosimilar business, the date to enter into the Interferon Alpha-2b Biosimilar market, Interferon Alpha-2b Biosimilar product introduction, recent developments, etc.
The major vendors covered:
Pharmstandard
Sicor Biotech
Intas
Reliance Life Science
CCL Pharmaceuticals
Tianjin Hualida
Biosidus
Amega
1 Study Coverage
1.1 Interferon Alpha-2b Biosimilar Product Introduction
1.2 Market Segments
1.3 Key Interferon Alpha-2b Biosimilar Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Interferon Alpha-2b Biosimilar Market Size Growth Rate by Type
1.4.2 Long-lasting Type
1.4.3 Ordinary Type
1.5 Market by Application
1.5.1 Global Interferon Alpha-2b Biosimilar Market Size Growth Rate by Application
1.5.2 Hepatitis C
1.5.3 Hepatitis B
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Interferon Alpha-2b Biosimilar Market Size, Estimates and Forecasts
2.1.1 Global Interferon Alpha-2b Biosimilar Revenue 2015-2026
2.1.2 Global Interferon Alpha-2b Biosimilar Sales 2015-2026
2.2 Global Interferon Alpha-2b Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Interferon Alpha-2b Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Interferon Alpha-2b Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Interferon Alpha-2b Biosimilar Competitor Landscape by Players
3.1 Interferon Alpha-2b Biosimilar Sales by Manufacturers
3.1.1 Interferon Alpha-2b Biosimilar Sales by Manufacturers (2015-2020)
3.1.2 Interferon Alpha-2b Biosimilar Sales Market Share by Manufacturers (2015-2020)
3.2 Interferon Alpha-2b Biosimilar Revenue by Manufacturers
3.2.1 Interferon Alpha-2b Biosimilar Revenue by Manufacturers (2015-2020)
3.2.2 Interferon Alpha-2b Biosimilar Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Interferon Alpha-2b Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Interferon Alpha-2b Biosimilar Revenue in 2019
3.2.5 Global Interferon Alpha-2b Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Interferon Alpha-2b Biosimilar Price by Manufacturers
3.4 Interferon Alpha-2b Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Interferon Alpha-2b Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Interferon Alpha-2b Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Interferon Alpha-2b Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Interferon Alpha-2b Biosimilar Market Size by Type (2015-2020)
4.1.1 Global Interferon Alpha-2b Biosimilar Sales by Type (2015-2020)
4.1.2 Global Interferon Alpha-2b Biosimilar Revenue by Type (2015-2020)
4.1.3 Interferon Alpha-2b Biosimilar Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Interferon Alpha-2b Biosimilar Market Size Forecast by Type (2021-2026)
4.2.1 Global Interferon Alpha-2b Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Interferon Alpha-2b Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Interferon Alpha-2b Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Interferon Alpha-2b Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Interferon Alpha-2b Biosimilar Market Size by Application (2015-2020)
5.1.1 Global Interferon Alpha-2b Biosimilar Sales by Application (2015-2020)
5.1.2 Global Interferon Alpha-2b Biosimilar Revenue by Application (2015-2020)
5.1.3 Interferon Alpha-2b Biosimilar Price by Application (2015-2020)
5.2 Interferon Alpha-2b Biosimilar Market Size Forecast by Application (2021-2026)
5.2.1 Global Interferon Alpha-2b Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Interferon Alpha-2b Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Interferon Alpha-2b Biosimilar Price Forecast by Application (2021-2026)
6 North America
6.1 North America Interferon Alpha-2b Biosimilar by Country
6.1.1 North America Interferon Alpha-2b Biosimilar Sales by Country
6.1.2 North America Interferon Alpha-2b Biosimilar Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Interferon Alpha-2b Biosimilar Market Facts & Figures by Type
6.3 North America Interferon Alpha-2b Biosimilar Market Facts & Figures by Application
7 Europe
7.1 Europe Interferon Alpha-2b Biosimilar by Country
7.1.1 Europe Interferon Alpha-2b Biosimilar Sales by Country
7.1.2 Europe Interferon Alpha-2b Biosimilar Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Interferon Alpha-2b Biosimilar Market Facts & Figures by Type
7.3 Europe Interferon Alpha-2b Biosimilar Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Interferon Alpha-2b Biosimilar by Region
8.1.1 Asia Pacific Interferon Alpha-2b Biosimilar Sales by Region
8.1.2 Asia Pacific Interferon Alpha-2b Biosimilar Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Interferon Alpha-2b Biosimilar Market Facts & Figures by Type
8.3 Asia Pacific Interferon Alpha-2b Biosimilar Market Facts & Figures by Application
9 Latin America
9.1 Latin America Interferon Alpha-2b Biosimilar by Country
9.1.1 Latin America Interferon Alpha-2b Biosimilar Sales by Country
9.1.2 Latin America Interferon Alpha-2b Biosimilar Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Interferon Alpha-2b Biosimilar Market Facts & Figures by Type
9.3 Central & South America Interferon Alpha-2b Biosimilar Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Interferon Alpha-2b Biosimilar by Country
10.1.1 Middle East and Africa Interferon Alpha-2b Biosimilar Sales by Country
10.1.2 Middle East and Africa Interferon Alpha-2b Biosimilar Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Interferon Alpha-2b Biosimilar Market Facts & Figures by Type
10.3 Middle East and Africa Interferon Alpha-2b Biosimilar Market Facts & Figures by Application
11 Company Profiles
11.1 Pharmstandard
11.1.1 Pharmstandard Corporation Information
11.1.2 Pharmstandard Description and Business Overview
11.1.3 Pharmstandard Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharmstandard Interferon Alpha-2b Biosimilar Products Offered
11.1.5 Pharmstandard Related Developments
11.2 Sicor Biotech
11.2.1 Sicor Biotech Corporation Information
11.2.2 Sicor Biotech Description and Business Overview
11.2.3 Sicor Biotech Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sicor Biotech Interferon Alpha-2b Biosimilar Products Offered
11.2.5 Sicor Biotech Related Developments
11.3 Intas
11.3.1 Intas Corporation Information
11.3.2 Intas Description and Business Overview
11.3.3 Intas Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Intas Interferon Alpha-2b Biosimilar Products Offered
11.3.5 Intas Related Developments
11.4 Reliance Life Science
11.4.1 Reliance Life Science Corporation Information
11.4.2 Reliance Life Science Description and Business Overview
11.4.3 Reliance Life Science Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Reliance Life Science Interferon Alpha-2b Biosimilar Products Offered
11.4.5 Reliance Life Science Related Developments
11.5 CCL Pharmaceuticals
11.5.1 CCL Pharmaceuticals Corporation Information
11.5.2 CCL Pharmaceuticals Description and Business Overview
11.5.3 CCL Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CCL Pharmaceuticals Interferon Alpha-2b Biosimilar Products Offered
11.5.5 CCL Pharmaceuticals Related Developments
11.6 Tianjin Hualida
11.6.1 Tianjin Hualida Corporation Information
11.6.2 Tianjin Hualida Description and Business Overview
11.6.3 Tianjin Hualida Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Tianjin Hualida Interferon Alpha-2b Biosimilar Products Offered
11.6.5 Tianjin Hualida Related Developments
11.7 Biosidus
11.7.1 Biosidus Corporation Information
11.7.2 Biosidus Description and Business Overview
11.7.3 Biosidus Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biosidus Interferon Alpha-2b Biosimilar Products Offered
11.7.5 Biosidus Related Developments
11.8 Amega
11.8.1 Amega Corporation Information
11.8.2 Amega Description and Business Overview
11.8.3 Amega Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Amega Interferon Alpha-2b Biosimilar Products Offered
11.8.5 Amega Related Developments
11.1 Pharmstandard
11.1.1 Pharmstandard Corporation Information
11.1.2 Pharmstandard Description and Business Overview
11.1.3 Pharmstandard Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharmstandard Interferon Alpha-2b Biosimilar Products Offered
11.1.5 Pharmstandard Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Interferon Alpha-2b Biosimilar Market Estimates and Projections by Region
12.1.1 Global Interferon Alpha-2b Biosimilar Sales Forecast by Regions 2021-2026
12.1.2 Global Interferon Alpha-2b Biosimilar Revenue Forecast by Regions 2021-2026
12.2 North America Interferon Alpha-2b Biosimilar Market Size Forecast (2021-2026)
12.2.1 North America: Interferon Alpha-2b Biosimilar Sales Forecast (2021-2026)
12.2.2 North America: Interferon Alpha-2b Biosimilar Revenue Forecast (2021-2026)
12.2.3 North America: Interferon Alpha-2b Biosimilar Market Size Forecast by Country (2021-2026)
12.3 Europe Interferon Alpha-2b Biosimilar Market Size Forecast (2021-2026)
12.3.1 Europe: Interferon Alpha-2b Biosimilar Sales Forecast (2021-2026)
12.3.2 Europe: Interferon Alpha-2b Biosimilar Revenue Forecast (2021-2026)
12.3.3 Europe: Interferon Alpha-2b Biosimilar Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Interferon Alpha-2b Biosimilar Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Interferon Alpha-2b Biosimilar Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Interferon Alpha-2b Biosimilar Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Interferon Alpha-2b Biosimilar Market Size Forecast by Region (2021-2026)
12.5 Latin America Interferon Alpha-2b Biosimilar Market Size Forecast (2021-2026)
12.5.1 Latin America: Interferon Alpha-2b Biosimilar Sales Forecast (2021-2026)
12.5.2 Latin America: Interferon Alpha-2b Biosimilar Revenue Forecast (2021-2026)
12.5.3 Latin America: Interferon Alpha-2b Biosimilar Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Interferon Alpha-2b Biosimilar Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Interferon Alpha-2b Biosimilar Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Interferon Alpha-2b Biosimilar Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Interferon Alpha-2b Biosimilar Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Interferon Alpha-2b Biosimilar Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Interferon Alpha-2b Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Interferon Alpha-2b Biosimilar Market Segments
Table 2. Ranking of Global Top Interferon Alpha-2b Biosimilar Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Interferon Alpha-2b Biosimilar Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Long-lasting Type
Table 5. Major Manufacturers of Ordinary Type
Table 6. Global Interferon Alpha-2b Biosimilar Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Interferon Alpha-2b Biosimilar Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Interferon Alpha-2b Biosimilar Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Interferon Alpha-2b Biosimilar Sales Market Share by Regions (2015-2020)
Table 10. Global Interferon Alpha-2b Biosimilar Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Interferon Alpha-2b Biosimilar Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Interferon Alpha-2b Biosimilar Sales Share by Manufacturers (2015-2020)
Table 13. Global Interferon Alpha-2b Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Interferon Alpha-2b Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon Alpha-2b Biosimilar as of 2019)
Table 15. Interferon Alpha-2b Biosimilar Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Interferon Alpha-2b Biosimilar Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Interferon Alpha-2b Biosimilar Price (2015-2020) (US$/Ton)
Table 18. Interferon Alpha-2b Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Interferon Alpha-2b Biosimilar Product Type
Table 20. Date of International Manufacturers Enter into Interferon Alpha-2b Biosimilar Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Interferon Alpha-2b Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 23. Global Interferon Alpha-2b Biosimilar Sales Share by Type (2015-2020)
Table 24. Global Interferon Alpha-2b Biosimilar Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Interferon Alpha-2b Biosimilar Revenue Share by Type (2015-2020)
Table 26. Interferon Alpha-2b Biosimilar Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Interferon Alpha-2b Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 28. Global Interferon Alpha-2b Biosimilar Sales Share by Application (2015-2020)
Table 29. North America Interferon Alpha-2b Biosimilar Sales by Country (2015-2020) (Kiloton)
Table 30. North America Interferon Alpha-2b Biosimilar Sales Market Share by Country (2015-2020)
Table 31. North America Interferon Alpha-2b Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Interferon Alpha-2b Biosimilar Revenue Market Share by Country (2015-2020)
Table 33. North America Interferon Alpha-2b Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 34. North America Interferon Alpha-2b Biosimilar Sales Market Share by Type (2015-2020)
Table 35. North America Interferon Alpha-2b Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 36. North America Interferon Alpha-2b Biosimilar Sales Market Share by Application (2015-2020)
Table 37. Europe Interferon Alpha-2b Biosimilar Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Interferon Alpha-2b Biosimilar Sales Market Share by Country (2015-2020)
Table 39. Europe Interferon Alpha-2b Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Interferon Alpha-2b Biosimilar Revenue Market Share by Country (2015-2020)
Table 41. Europe Interferon Alpha-2b Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Interferon Alpha-2b Biosimilar Sales Market Share by Type (2015-2020)
Table 43. Europe Interferon Alpha-2b Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Interferon Alpha-2b Biosimilar Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Interferon Alpha-2b Biosimilar Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Interferon Alpha-2b Biosimilar Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Interferon Alpha-2b Biosimilar Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Interferon Alpha-2b Biosimilar Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Interferon Alpha-2b Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Interferon Alpha-2b Biosimilar Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Interferon Alpha-2b Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Interferon Alpha-2b Biosimilar Sales Market Share by Application (2015-2020)
Table 53. Latin America Interferon Alpha-2b Biosimilar Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Interferon Alpha-2b Biosimilar Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Interferon Alpha-2b Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Interferon Alpha-2b Biosimilar Revenue Market Share by Country (2015-2020)
Table 57. Latin America Interferon Alpha-2b Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Interferon Alpha-2b Biosimilar Sales Market Share by Type (2015-2020)
Table 59. Latin America Interferon Alpha-2b Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Interferon Alpha-2b Biosimilar Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Interferon Alpha-2b Biosimilar Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Interferon Alpha-2b Biosimilar Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Interferon Alpha-2b Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Interferon Alpha-2b Biosimilar Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Interferon Alpha-2b Biosimilar Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Interferon Alpha-2b Biosimilar Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Interferon Alpha-2b Biosimilar Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Interferon Alpha-2b Biosimilar Sales Market Share by Application (2015-2020)
Table 69. Pharmstandard Corporation Information
Table 70. Pharmstandard Description and Major Businesses
Table 71. Pharmstandard Interferon Alpha-2b Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Pharmstandard Product
Table 73. Pharmstandard Recent Development
Table 74. Sicor Biotech Corporation Information
Table 75. Sicor Biotech Description and Major Businesses
Table 76. Sicor Biotech Interferon Alpha-2b Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Sicor Biotech Product
Table 78. Sicor Biotech Recent Development
Table 79. Intas Corporation Information
Table 80. Intas Description and Major Businesses
Table 81. Intas Interferon Alpha-2b Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. Intas Product
Table 83. Intas Recent Development
Table 84. Reliance Life Science Corporation Information
Table 85. Reliance Life Science Description and Major Businesses
Table 86. Reliance Life Science Interferon Alpha-2b Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Reliance Life Science Product
Table 88. Reliance Life Science Recent Development
Table 89. CCL Pharmaceuticals Corporation Information
Table 90. CCL Pharmaceuticals Description and Major Businesses
Table 91. CCL Pharmaceuticals Interferon Alpha-2b Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. CCL Pharmaceuticals Product
Table 93. CCL Pharmaceuticals Recent Development
Table 94. Tianjin Hualida Corporation Information
Table 95. Tianjin Hualida Description and Major Businesses
Table 96. Tianjin Hualida Interferon Alpha-2b Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Tianjin Hualida Product
Table 98. Tianjin Hualida Recent Development
Table 99. Biosidus Corporation Information
Table 100. Biosidus Description and Major Businesses
Table 101. Biosidus Interferon Alpha-2b Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 102. Biosidus Product
Table 103. Biosidus Recent Development
Table 104. Amega Corporation Information
Table 105. Amega Description and Major Businesses
Table 106. Amega Interferon Alpha-2b Biosimilar Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 107. Amega Product
Table 108. Amega Recent Development
Table 109. Global Interferon Alpha-2b Biosimilar Sales Forecast by Regions (2021-2026) (Kiloton)
Table 110. Global Interferon Alpha-2b Biosimilar Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Interferon Alpha-2b Biosimilar Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Interferon Alpha-2b Biosimilar Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Interferon Alpha-2b Biosimilar Sales Forecast by Country (2021-2026) (Kiloton)
Table 114. North America: Interferon Alpha-2b Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Interferon Alpha-2b Biosimilar Sales Forecast by Country (2021-2026) (Kiloton)
Table 116. Europe: Interferon Alpha-2b Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Interferon Alpha-2b Biosimilar Sales Forecast by Region (2021-2026) (Kiloton)
Table 118. Asia Pacific: Interferon Alpha-2b Biosimilar Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Interferon Alpha-2b Biosimilar Sales Forecast by Country (2021-2026) (Kiloton)
Table 120. Latin America: Interferon Alpha-2b Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Interferon Alpha-2b Biosimilar Sales Forecast by Country (2021-2026) (Kiloton)
Table 122. Middle East and Africa: Interferon Alpha-2b Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Interferon Alpha-2b Biosimilar Players
Table 127. Interferon Alpha-2b Biosimilar Customers List
Table 128. Interferon Alpha-2b Biosimilar Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Interferon Alpha-2b Biosimilar Product Picture
Figure 2. Global Interferon Alpha-2b Biosimilar Sales Market Share by Type in 2020 & 2026
Figure 3. Long-lasting Type Product Picture
Figure 4. Ordinary Type Product Picture
Figure 5. Global Interferon Alpha-2b Biosimilar Sales Market Share by Application in 2020 & 2026
Figure 6. Hepatitis C
Figure 7. Hepatitis B
Figure 8. Other
Figure 9. Interferon Alpha-2b Biosimilar Report Years Considered
Figure 10. Global Interferon Alpha-2b Biosimilar Market Size 2015-2026 (US$ Million)
Figure 11. Global Interferon Alpha-2b Biosimilar Sales 2015-2026 (Kiloton)
Figure 12. Global Interferon Alpha-2b Biosimilar Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Interferon Alpha-2b Biosimilar Sales Market Share by Region (2015-2020)
Figure 14. Global Interferon Alpha-2b Biosimilar Sales Market Share by Region in 2019
Figure 15. Global Interferon Alpha-2b Biosimilar Revenue Market Share by Region (2015-2020)
Figure 16. Global Interferon Alpha-2b Biosimilar Revenue Market Share by Region in 2019
Figure 17. Global Interferon Alpha-2b Biosimilar Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Interferon Alpha-2b Biosimilar Revenue in 2019
Figure 19. Interferon Alpha-2b Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Interferon Alpha-2b Biosimilar Sales Market Share by Type (2015-2020)
Figure 21. Global Interferon Alpha-2b Biosimilar Sales Market Share by Type in 2019
Figure 22. Global Interferon Alpha-2b Biosimilar Revenue Market Share by Type (2015-2020)
Figure 23. Global Interferon Alpha-2b Biosimilar Revenue Market Share by Type in 2019
Figure 24. Global Interferon Alpha-2b Biosimilar Market Share by Price Range (2015-2020)
Figure 25. Global Interferon Alpha-2b Biosimilar Sales Market Share by Application (2015-2020)
Figure 26. Global Interferon Alpha-2b Biosimilar Sales Market Share by Application in 2019
Figure 27. Global Interferon Alpha-2b Biosimilar Revenue Market Share by Application (2015-2020)
Figure 28. Global Interferon Alpha-2b Biosimilar Revenue Market Share by Application in 2019
Figure 29. North America Interferon Alpha-2b Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 30. North America Interferon Alpha-2b Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Interferon Alpha-2b Biosimilar Sales Market Share by Country in 2019
Figure 32. North America Interferon Alpha-2b Biosimilar Revenue Market Share by Country in 2019
Figure 33. U.S. Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 34. U.S. Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 36. Canada Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Interferon Alpha-2b Biosimilar Market Share by Type in 2019
Figure 38. North America Interferon Alpha-2b Biosimilar Market Share by Application in 2019
Figure 39. Europe Interferon Alpha-2b Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 40. Europe Interferon Alpha-2b Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Interferon Alpha-2b Biosimilar Sales Market Share by Country in 2019
Figure 42. Europe Interferon Alpha-2b Biosimilar Revenue Market Share by Country in 2019
Figure 43. Germany Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 44. Germany Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 46. France Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 48. U.K. Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 50. Italy Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 52. Russia Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Interferon Alpha-2b Biosimilar Market Share by Type in 2019
Figure 54. Europe Interferon Alpha-2b Biosimilar Market Share by Application in 2019
Figure 55. Asia Pacific Interferon Alpha-2b Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 56. Asia Pacific Interferon Alpha-2b Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Interferon Alpha-2b Biosimilar Sales Market Share by Region in 2019
Figure 58. Asia Pacific Interferon Alpha-2b Biosimilar Revenue Market Share by Region in 2019
Figure 59. China Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 60. China Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 62. Japan Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 64. South Korea Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 66. India Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 68. Australia Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 70. Taiwan Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 72. Indonesia Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 74. Thailand Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 76. Malaysia Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 78. Philippines Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 80. Vietnam Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Interferon Alpha-2b Biosimilar Market Share by Type in 2019
Figure 82. Asia Pacific Interferon Alpha-2b Biosimilar Market Share by Application in 2019
Figure 83. Latin America Interferon Alpha-2b Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 84. Latin America Interferon Alpha-2b Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Interferon Alpha-2b Biosimilar Sales Market Share by Country in 2019
Figure 86. Latin America Interferon Alpha-2b Biosimilar Revenue Market Share by Country in 2019
Figure 87. Mexico Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 88. Mexico Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 90. Brazil Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 92. Argentina Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Interferon Alpha-2b Biosimilar Market Share by Type in 2019
Figure 94. Latin America Interferon Alpha-2b Biosimilar Market Share by Application in 2019
Figure 95. Middle East and Africa Interferon Alpha-2b Biosimilar Sales Growth Rate 2015-2020 (Kiloton)
Figure 96. Middle East and Africa Interferon Alpha-2b Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Interferon Alpha-2b Biosimilar Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Interferon Alpha-2b Biosimilar Revenue Market Share by Country in 2019
Figure 99. Turkey Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 100. Turkey Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 102. Saudi Arabia Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Interferon Alpha-2b Biosimilar Sales Growth Rate (2015-2020) (Kiloton)
Figure 104. UAE Interferon Alpha-2b Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Interferon Alpha-2b Biosimilar Market Share by Type in 2019
Figure 106. Middle East and Africa Interferon Alpha-2b Biosimilar Market Share by Application in 2019
Figure 107. North America Interferon Alpha-2b Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 108. North America Interferon Alpha-2b Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Interferon Alpha-2b Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 110. Europe Interferon Alpha-2b Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Interferon Alpha-2b Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 112. Asia Pacific Interferon Alpha-2b Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Interferon Alpha-2b Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 114. Latin America Interferon Alpha-2b Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Interferon Alpha-2b Biosimilar Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 116. Middle East and Africa Interferon Alpha-2b Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
バイオシミラーモノクローナル抗体の世界市場（～2026年） Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…- バイオシミラー試験・開発サービスの世界市場（～2026年） The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified…
- α放射体の世界市場（～2026年） Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues t…
- インターロイキン1アルファの世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 Alpha Market The global Interleukin 1 Alpha market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 Alpha Scope and Market Size Interleukin 1 Alpha market is seg…
- アルファ2Cアドレナリン受容体の世界市場（～2026年） Market Analysis and Insights: Global Alpha 2C Adrenergic Receptor Market The global Alpha 2C Adrenergic Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alpha 2C Adrenergic Receptor Scope and Market Size Alpha …